Slovakia Country Drug Report 2018

Quality assurance

The current national drug strategy supports the use and exchange of best practices and the implementation of standards in the areas of prevention, early detection and intervention, reduction of risks and harms, treatment, rehabilitation, social reintegration and recovery.

The Healthcare Surveillance Authority is responsible for promoting quality assurance in the drug treatment sector and maintains a list of providers and guidelines on its website. Some basic quality standards are required as a part of the set-up process for services. The quality of drug-related inpatient care is determined by the framework standards established by the Ministry of Health and the chief expert of the Slovak Republic in the field of psychiatry.

Implementation of drug prevention in schools is supported by the Educational and Psychological Counselling and Prevention Centres, the Methodological and Educational Centres, the National Institute for Education, the Institute of Information and Prognoses of Education of the Centre of Scientific and Technical Information, and the Research Institute for Child Psychology and Pathopsychology. A special web portal has been designed to support teachers in implementing and drafting prevention programmes based on best practice.

Slovakia main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.